According to ESSA Pharma's latest financial reports the company has $0.14 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | $0.14 B | -11.46% |
2022-09-30 | $0.16 B | -14.21% |
2021-09-30 | $0.19 B | 148.85% |
2020-09-30 | $78.33 M | 46.9% |
2019-09-30 | $53.32 M | 259.58% |
2018-09-30 | $14.82 M | 274.74% |
2017-09-30 | $3.95 M | -55.96% |
2016-09-30 | $8.98 M | 468.93% |
2015-09-30 | $1.57 M | -57.32% |
2014-09-30 | $3.69 M |